AUDHYA PAUL K. (Chief Medical Officer) sold 3.7% of their position (5.35K shares) of KALVISTA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $83.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/24/2026ACC: 0001860131-26-000003
Officer· Chief Medical Officer
Since May 2021
-5.35K
Net shares
Net seller
$83.3K
Total sold
1
Open market trades
0B · 1S
5
Total transactions
11.25K acquired · 16.60K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+6.25K
Price / share
—
Trade value
—
% of position
4.7%
2/21/2026
133.09K→139.34K
Common Stock
Direct
Shares
+5K
Price / share
—
Trade value
—
% of position
3.6%
2/22/2026
139.34K→144.34K
Common Stock
Direct
Shares
−5.35K
Price / share
$15.57
Trade value
$83.34K
% of position
3.7%
2/23/2026
144.34K→138.98K
Total
Net shares
+5.90K
Net value
-$83.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/21/2026 | M · Option Exercise | +6.25K | — | — | 4.7% | 133.09K | 139.34K |
| Common Stock Direct | 2/22/2026 | M · Option Exercise | +5K | — | — | 3.6% | 139.34K | 144.34K |
| Common Stock Direct | 2/23/2026 | S · Sale | −5.35K | $15.57 | $83.34K | 3.7% | 144.34K | 138.98K |
| Total | +5.90K | -$83.34K | ||||||
Derivative Transactions2
Restricted Stock Unit
Direct
Converts to
Common Stock
6.25K shares
Shares
−6.25K
Strike price
Held after
75K
Exercisable
—
2/21/2026
Restricted Stock Unit
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
Held after
45K
Exercisable
—
2/22/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock6.25K shares | 2/21/2026 | M · Option Exercise | −6.25K | — | 75K | |
| Restricted Stock Unit Direct | Common Stock5K shares | 2/22/2026 | M · Option Exercise | −5K | — | 45K |